With surveys indicating that 70 percent of clinical trials across Asia, Europe, Canada and Latin America experience dela...
Singapore: Nature Biotechnology has published a peer-reviewed paper co-authored by the Biotechnology Industry Organizati...
Singapore: Clinical research company, CPR Pharma Services, launched a new laboratory, in Adelaide, Australia, to provide...
Singapore: Ms Radhika (name changed), a patient who has been a part of the clinical trials being done on a drug that cou...
New Zealand is taking steps to improve the environment surrounding the country's clinical trial domain. With no accurate...
Singapore: The discussion was led by Ms Suneela Thatte, president, ISCR, and Dr Bapsy, senior consultant and head of dep...
Singapore: Merck Serono and Quintiles have signed a new, five-year clinical development agreement. This strategic collab...
Singapore: ACM Global Central Laboratory, US-based diagnostic central laboratory, has expanded in China with the opening...
Singapore: Sihuan Pharmaceuticals recently announced that its subsidiary Shandong Xuanzhu has partnered with Covance, a ...
Australia, often regarded by market experts as the most mature clinical research market in Asia Pacific, has leveraged s...
Singapore: Pluristem Therapeutics, an Israel-based developer of placenta-based cell therapy products, has announced that...
Singapore: Quintiles has officially opened Greater China Regional Headquarters, further expanding its ability to help Ch...
Singapore: Ms Tanya Plibersek, federal Minister for Health, and Mr Greg Combet, Minister for Innovation and Industry, Au...
Indian company Bharat Serums and Vaccines boasts of a product portfolio that includes many firsts in India and the world...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: The Indian Supreme Court on July 26 heard a Public Interest Litigation (PIL) seeking a ban on drug trials in ...
Singapore: Indian pharmaceutical company based in Bangalore, Jubilant Biosys has said that the US Food and Drug Administ...
Singapore: Brisbane-based R&D company Alchemia has recruited the 390th patient for the pivotal phase III clinical tr...
